Formycon CFO Enno Spillner interviewed by Andreas Schmidt from the SdK
Formycon CFO Enno Spillner interviewed by Andreas Schmidt from the SdK March…
Update on Biosimilar Projects and US Market Dynamics
Update on Biosimilar Projects and US Market Dynamics February 17, 2025 The…
Looking back on a fantastic year
2024 in a nutshell January 6, 2025 2024 was a special year for Formycon. With…
Formycon & mwb-Research Roundtable
mwb-research Roundtable December 12, 2024 In the mwb Research Roundtable, we…
Growth and future of biotechnology: opportunities through biosimilars
Growth and future of biotechnology: opportunities through biosimilars Guest…
An interview with our Executive Board
An Interview with our Executive Board 13. August 2024 Formycon is regarded as…
